These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30079005)

  • 1. Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data.
    Choi WS; Ryu SY; Lee J; Hong SB; Eom JS; Shin J; Park KH; Ohk T; Chung JW; Chung DR; Kim DK; Lee SR; Kim PY; Kim SW; Noh JY; Song JY; Cheong HJ; Kim WJ
    J Korean Med Sci; 2018 Aug; 33(32):e212. PubMed ID: 30079005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation.
    Komeda T; Ishii S; Itoh Y; Ariyasu Y; Sanekata M; Yoshikawa T; Shimada J
    J Infect Chemother; 2014 Nov; 20(11):689-95. PubMed ID: 25131292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation.
    Komeda T; Ishii S; Itoh Y; Ariyasu Y; Sanekata M; Yoshikawa T; Shimada J
    J Infect Chemother; 2015 Mar; 21(3):194-201. PubMed ID: 25523716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors.
    Komeda T; Ishii S; Itoh Y; Sanekata M; Yoshikawa T; Shimada J
    J Infect Chemother; 2016 Oct; 22(10):677-84. PubMed ID: 27497712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
    Kohno S; Yen MY; Cheong HJ; Hirotsu N; Ishida T; Kadota J; Mizuguchi M; Kida H; Shimada J;
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5267-76. PubMed ID: 21825298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peramivir: A Review in Uncomplicated Influenza.
    Scott LJ
    Drugs; 2018 Sep; 78(13):1363-1370. PubMed ID: 30196350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection.
    Kohno S; Kida H; Mizuguchi M; Shimada J;
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4568-74. PubMed ID: 20713668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.
    Sorbello A; Jones SC; Carter W; Struble K; Boucher R; Truffa M; Birnkrant D; Gada N; Camilli S; Chan I; Dallas S; Scales T; Kosko R; Thompson E; Goodman J; Francis H; Dal Pan G
    Clin Infect Dis; 2012 Jul; 55(1):1-7. PubMed ID: 22491501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of peramivir for influenza treatment.
    Hata A; Akashi-Ueda R; Takamatsu K; Matsumura T
    Drug Des Devel Ther; 2014; 8():2017-38. PubMed ID: 25368514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.
    Louie JK; Yang S; Yen C; Acosta M; Schechter R; Uyeki TM
    PLoS One; 2012; 7(6):e40261. PubMed ID: 22768265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous peramivir for treatment of influenza in hospitalized patients.
    Ison MG; Fraiz J; Heller B; Jauregui L; Mills G; O'Riordan W; O'Neil B; Playford EG; Rolf JD; Sada-Diaz E; Elder J; Collis P; Hernandez JE; Sheridan WP
    Antivir Ther; 2014; 19(4):349-61. PubMed ID: 23985625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.
    Lee J; Park JH; Jwa H; Kim YH
    Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.
    Ison MG; Hui DS; Clezy K; O'Neil BJ; Flynt A; Collis PJ; Simon TJ; Alexander WJ
    Antivir Ther; 2013; 18(5):651-61. PubMed ID: 23111657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients.
    Kohno S; Kida H; Mizuguchi M; Hirotsu N; Ishida T; Kadota J; Shimada J;
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2803-12. PubMed ID: 21464252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.
    de Jong MD; Ison MG; Monto AS; Metev H; Clark C; O'Neil B; Elder J; McCullough A; Collis P; Sheridan WP
    Clin Infect Dis; 2014 Dec; 59(12):e172-85. PubMed ID: 25115871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment.
    Chen JY; Wei SK; Lai CC; Weng TS; Wang HH
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32033501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials.
    Whitley R; Laughlin A; Carson S; Mitha E; Tellier G; Stich M; Elder J; Alexander WJ; Dobo S; Collis P; Sheridan WP
    Antivir Ther; 2015; 20(7):709-19. PubMed ID: 25318121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010.
    Yu Y; Garg S; Yu PA; Kim HJ; Patel A; Merlin T; Redd S; Uyeki TM
    Clin Infect Dis; 2012 Jul; 55(1):8-15. PubMed ID: 22491506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
    Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.
    Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
    Clin Respir J; 2015 Apr; 9(2):228-32. PubMed ID: 24612842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.